2026
article
OpenAlex
Ananthan Sadagopan, Anurag Sodhi, William J. Gibson
Ligand-protein binding prediction remains a central challenge, yet the contribution of ligand-side information to performance is unclear. We combined pretrained molecular embeddings with TabPFNv2 to build per-target classifiers without protein features. Across 159 BindingDB targets, models assigned higher probabilities to annotated binders …
us
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Corrie Painter, Saud AlDubayan, Eliezer Van Allen, William J. Gibson
Abstract Background: Angiosarcoma (AS) is an anatomically heterogeneous ultra-rare sarcoma with no approved precision therapies. Head/face/neck/scalp (HNFS) AS is the only subset with reported immune checkpoint inhibitor activity. Whether AS subsets express clinically actionable antibody–drug conjugate (ADC) targets remains unclear. Methods: From …
us
(code pays fourni par la source)
Accès ouvert
2026
erratum
OpenAlex
Nikola Dragisic, Emily R. Backes, Lindsey Malloy-Walton, Edo K. Bedzra et autres
[This corrects the article DOI: 10.19102/icrm.2025.16113.].
us
(code pays fourni par la source)
2026
article
OpenAlex
Justine V. Cohen, Mofei Liu, Grace Rogers, Michael Manos et autres
Patients with resectable stage III-IV melanoma are at high risk of recurrence following surgical excision. Neoadjuvant therapy (NEO) with immune checkpoint inhibition (ICI) improves event-free survival and may allow for pathologic treatment response assessment with potential adjuvant therapy de-escalation. Identification of a …
us
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Ananthan Sadagopan, Maximilian Carson, Eriks J. Zamurs, Shanivi Srikonda et autres
The targeted modulation of gene expression with bifunctional small molecules enables the precise control of cellular and biological processes. To screen for ligands that could be used to induce gene expression, we conjugated the high affinity FKBP(F36V) binder, AP1867, to known high-affinity …
us
(code pays fourni par la source)
2026
article
OpenAlex
Erica Pimenta, Amanda Garza, Sabrina Y. Camp, Jihye Park et autres
Sarcomas are rare cancers thought to arise from aberrant mesenchymal stem cell (MSC) differentiation. Liposarcoma (LPS) is among the most commonly diagnosed sarcomas and provides insights into dysfunctional differentiation through its well- and dedifferentiated subtypes (WDLPS and DDLPS). Despite differences in histology …
us
(code pays fourni par la source)
Accès ouvert
2025
erratum
OpenAlex
Ananthan Sadagopan, Eriks J. Zamurs, Nicholas Garaffo, Heng-Jui Chang et autres
In the version of the article initially published, the x -axis label for Fig. 4e was “log 10 (concentration), pM” but should have been “log 10 (concentration), nM” and has now been corrected in the HTML and PDF versions of the article.
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Ananthan Sadagopan, Eriks J. Zamurs, Nicholas Garaffo, Heng-Jui Chang et autres
Abstract TP53 mutant cancers are associated with approximately half of cancer deaths. The most common mechanism of p53 inactivation involves missense mutations. Such mutations in TP53 result in a robust upregulation of the p53 protein. Here, we demonstrate an induced proximity approach …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Nikola Dragisic, Lindsey Malloy-Walton, Edo Bedzra, William J. Gibson et autres
Experience with the Aurora extravascular (EV) implantable cardioverter-defibrillator (ICD) (Medtronic, Minneapolis, MN, USA) remains limited among pediatric centers in contrast to its broader implantation in adults. We evaluated our single-center experience with the EV ICD as part of our standard ICD options …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Kirsten Kübler, Agostina Nardone, Shankara Anand, Daniel Gurevich et autres
Mutagenic processes and clonal selection contribute to the development of therapy-associated secondary neoplasms, a known complication of cancer treatment. The association between tamoxifen therapy and secondary uterine cancers is uncommon but well established; however, the genetic mechanisms underlying tamoxifen-driven tumorigenesis remain unclear. …
us, de, il, nl
(code pays fourni par la source)
2025
article
OpenAlex
Lavina Desai, R. Juhl, K. Garner, V. Benvenuto et autres
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Leifei Chen, William J. Gibson, S Sanne, B Boulmay